Why BioMarin Pharmaceuticals Fell 6.9% on Thursday
BioMarin Pharmaceuticals (NASDAQ: BMRN), a biopharmaceutical company that specializes in finding therapies for rare genetic diseases, saw its shares drop 6.9% on Thursday after falling as much as 9.8% earlier in the day. The company reported third-quarter earnings after the market closed on Wednesday, and investors were not that impressed. Earnings per share (EPS) for nine months came in at a loss of $0.04, compared to an EPS loss of $0.20 in the first nine months of 2021.